Avapro: Advanced Blood Pressure Control for Lasting Cardiovascular Health
Avapro
| Product dosage: 150mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.60 | $48.00 (0%) | 🛒 Add to cart |
| 60 | $1.12 | $96.00 $67.00 (30%) | 🛒 Add to cart |
| 90 | $0.96 | $144.00 $86.00 (40%) | 🛒 Add to cart |
| 120 | $0.88 | $192.00 $105.00 (45%) | 🛒 Add to cart |
| 180 | $0.80 | $288.00 $144.00 (50%) | 🛒 Add to cart |
| 270 | $0.75 | $432.00 $203.00 (53%) | 🛒 Add to cart |
| 360 | $0.72
Best per pill | $576.00 $259.00 (55%) | 🛒 Add to cart |
| Product dosage: 300mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.93 | $58.00 (0%) | 🛒 Add to cart |
| 60 | $1.37 | $116.00 $82.00 (29%) | 🛒 Add to cart |
| 90 | $1.19 | $174.00 $107.00 (39%) | 🛒 Add to cart |
| 120 | $1.08 | $232.00 $130.00 (44%) | 🛒 Add to cart |
| 180 | $0.99 | $348.00 $179.00 (49%) | 🛒 Add to cart |
| 270 | $0.93
Best per pill | $522.00 $251.00 (52%) | 🛒 Add to cart |
Synonyms | |||
Avapro (irbesartan) is an angiotensin II receptor blocker (ARB) prescribed for the management of hypertension (high blood pressure) and to provide nephroprotection in patients with type 2 diabetes and hypertension. It works by blocking the action of certain natural substances that tighten blood vessels, allowing blood to flow more smoothly and the heart to pump more efficiently. This medication is trusted by healthcare professionals for its efficacy, tolerability, and once-daily dosing convenience, helping patients achieve and maintain target blood pressure levels with a well-established safety profile.
Features
- Active ingredient: Irbesartan
- Available in tablet strengths: 75 mg, 150 mg, 300 mg
- Administration: Oral, once daily
- Onset of action: Within 1–2 weeks for full antihypertensive effect
- Half-life: 11–15 hours
- Bioavailability: 60–80%
- Excretion: Primarily fecal and renal
- Pregnancy category: D (contraindicated in second and third trimesters)
Benefits
- Effectively lowers systolic and diastolic blood pressure, reducing strain on the heart and arteries.
- Helps protect kidney function in hypertensive patients with type 2 diabetes and elevated serum creatinine.
- Minimizes risk of stroke, heart attack, and other cardiovascular events associated with uncontrolled hypertension.
- Supports long-term vascular health through consistent 24-hour blood pressure control.
- Generally well-tolerated with a low incidence of side effects like cough compared to ACE inhibitors.
- Convenient once-daily dosing supports adherence and simplifies treatment regimens.
Common use
Avapro is primarily indicated for the treatment of hypertension, either as monotherapy or in combination with other antihypertensive agents. It is also used for renal protection in patients with type 2 diabetes mellitus and hypertension, demonstrated to reduce the rate of progression of nephropathy (e.g., doubling of serum creatinine, end-stage renal disease). It may be prescribed off-label in certain cases of heart failure, though this is not an FDA-approved indication.
Dosage and direction
The recommended initial dose of Avapro for hypertension is 150 mg once daily. Dosage may be increased to 300 mg once daily if blood pressure remains uncontrolled. For volume-depleted patients (e.g., those on diuretics), consider starting at 75 mg once daily. For nephropathy in type 2 diabetic patients, the recommended maintenance dose is 300 mg once daily. Tablets may be taken with or without food. Consistency in daily timing is advised for optimal therapeutic effect.
Precautions
- Monitor renal function and electrolytes periodically, especially in patients with renal impairment, heart failure, or those on concomitant NSAIDs.
- Avoid use in pregnancy due to risk of fetal injury or death; discontinue if pregnancy is detected.
- Use with caution in patients with hepatic impairment, as irbesartan is extensively metabolized in the liver.
- Symptomatic hypotension may occur in volume-depleted or salt-depleted patients; correct volume depletion prior to administration.
- Dual blockade of the renin-angiotensin system (e.g., with ACE inhibitors) may increase risks of hyperkalemia, hypotension, and renal impairment.
- Not recommended for use in pediatric patients.
Contraindications
- Hypersensitivity to irbesartan or any component of the formulation.
- Concomitant use with aliskiren in patients with diabetes.
- Pregnancy (second and third trimesters).
- Severe hepatic impairment (Child-Pugh class C).
- Bilateral renal artery stenosis or stenosis to a solitary kidney.
Possible side effect
Common side effects may include dizziness, fatigue, musculoskeletal pain, diarrhea, dyspepsia, and upper respiratory infection. Less frequently, orthostatic hypotension, hyperkalemia, elevated serum creatinine, rash, and angioedema (rare) may occur. Most side effects are mild and transient. Report any signs of allergic reaction (e.g., swelling of face, lips, throat), persistent lightheadedness, or symptoms suggesting renal impairment to a healthcare provider promptly.
Drug interaction
- Potassium supplements, potassium-sparing diuretics, or salt substitutes containing potassium: increased risk of hyperkalemia.
- NSAIDs (e.g., ibuprofen, naproxen): may reduce antihypertensive effect and worsen renal function.
- Lithium: increased lithium levels and toxicity risk; monitor lithium serum concentrations.
- Other antihypertensive agents: additive hypotensive effects.
- ACE inhibitors or aliskiren: increased risk of renal impairment, hyperkalemia, and hypotension (avoid combination in patients with diabetes).
- Rifampin: may decrease irbesartan plasma concentrations.
Missed dose
If a dose is missed, take it as soon as remembered the same day. If it is nearly time for the next dose, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one. Consistent daily use is important for maintaining blood pressure control.
Overdose
Symptoms of overdose may include severe hypotension, tachycardia, bradycardia, dizziness, and possible renal failure. Management involves supportive care, including IV fluids and vasopressors if needed to maintain blood pressure. Hemodialysis is not effective for removing irbesartan due to high protein binding. Contact a poison control center or seek emergency medical attention immediately if overdose is suspected.
Storage
Store at room temperature (20–25°C or 68–77°F), in a dry place, protected from light and moisture. Keep in the original container with the lid tightly closed. Do not store in bathrooms or near sinks. Keep out of reach of children and pets. Do not use beyond the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Do not disregard professional medical advice or delay in seeking it because of something you have read here. Individual patient responses and needs may vary.
Reviews
Clinical studies and patient reports consistently affirm Avapro’s effectiveness in controlling hypertension and providing renal protection. Many users note significant and stable blood pressure reduction with minimal side effects. Healthcare providers appreciate its reliable pharmacokinetics and favorable tolerability profile, especially in diabetic patients. Some users report dizziness during initial therapy, which often resolves with continued use. Adherence is generally high due to once-daily dosing. Always discuss your personal experience and any concerns with your prescribing physician.